# The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme

> **NCT01429779** · PHASE4 · UNKNOWN · sponsor: **Maastricht University Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Liver Diseases

## Interventions

- **DRUG:** Movicol

## Key facts

- **NCT ID:** NCT01429779
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429779, "The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme". Retrieved via AI Analytics 2026-06-19 from https://api.ai-analytics.org/clinical/NCT01429779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*